Literature DB >> 28645713

Propranolol kinetics in plasma from severely burned adults.

Ashley N Guillory1, David N Herndon2, Michael B Silva2, Clark R Andersen2, Erge Edgu-Fry2, Oscar E Suman2, Celeste C Finnerty3.   

Abstract

OBJECTIVES: The aim of this study was to determine the appropriate propranolol dosing strategy for reducing heart rate in severely burned adults.
METHODS: A total of 26 patients (≥18 years) with burns covering ≥30% of the total body surface area were included in this IRB-approved study. Plasma propranolol concentrations were determined in a placebo group (n=10) or following one of three dosing strategies: Q6 (n=4), Q8 (n=6), and Q24 (n=6). Blood was collected just before dosing and at regular intervals over two dosing periods with corresponding heart rate and blood pressure recordings. Statistical significance was determined by one-way ANOVA followed by the appropriate post-hoc test.
RESULTS: Heart rate was 86±2 bpm for Q6, 93±3 bpm for Q8, and 90±4 bpm for Q24. The Q8 group had a significantly higher heart rate than the Q6 group (p=0.0001). Plasma propranolol concentrations were significantly higher in the Q6 dosing strategy than in the Q8 dosing strategy (p=0.02).
CONCLUSIONS: Heart rate can be decreased to a similar degree with Q6 and Q24 dosing strategies, with the Q8 dosing strategy being less effective. Q6 dosing is recommended to maintain reduced heart rate throughout dosing periods.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Adult; Burns; Heart rate; β-Adrenergic receptor antagonists

Mesh:

Substances:

Year:  2017        PMID: 28645713      PMCID: PMC8173765          DOI: 10.1016/j.burns.2016.10.019

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  23 in total

Review 1.  Support of the metabolic response to burn injury.

Authors:  David N Herndon; Ronald G Tompkins
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

2.  Myocardial function and haemodynamics in extensive burn trauma: evaluation by clinical signs, invasive monitoring, echocardiography and cytokine concentrations. A prospective clinical study.

Authors:  A Papp; A Uusaro; I Parviainen; J Hartikainen; E Ruokonen
Journal:  Acta Anaesthesiol Scand       Date:  2003-11       Impact factor: 2.105

3.  Understanding the long-term impacts of burn on the cardiovascular system.

Authors:  Janine M Duke; Sean M Randall; Mark W Fear; James H Boyd; Suzanne Rea; Fiona M Wood
Journal:  Burns       Date:  2016-01-14       Impact factor: 2.744

4.  Studies of the absorption and removal of propranolol in hypertensive patients during therapy.

Authors:  C A Chidsey; P Morselli; G Bianchetti; A Morganti; G Leonetti; A Zanchetti
Journal:  Circulation       Date:  1975-08       Impact factor: 29.690

5.  Propranolol decreases cardiac work in a dose-dependent manner in severely burned children.

Authors:  Felicia N Williams; David N Herndon; Gabriela A Kulp; Marc G Jeschke
Journal:  Surgery       Date:  2011-02       Impact factor: 3.982

6.  Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.

Authors:  C Von Bahr; J Hermansson; K Tawara
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

7.  The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.

Authors:  M J Serlin; M L Orme; M MacIver; G J Green; R G Sibeon; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

8.  Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism.

Authors:  P K Minifee; R E Barrow; S Abston; M Desai; D N Herndon
Journal:  J Pediatr Surg       Date:  1989-08       Impact factor: 2.545

9.  Long-term persistance of the pathophysiologic response to severe burn injury.

Authors:  Marc G Jeschke; Gerd G Gauglitz; Gabriela A Kulp; Celeste C Finnerty; Felicia N Williams; Robert Kraft; Oscar E Suman; Ronald P Mlcak; David N Herndon
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Long-term musculoskeletal morbidity after adult burn injury: a population-based cohort study.

Authors:  Sean M Randall; Mark W Fear; Fiona M Wood; Suzanne Rea; James H Boyd; Janine M Duke
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

View more
  4 in total

Review 1.  Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.

Authors:  Eduardo I Gus; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Burns       Date:  2019-12-15       Impact factor: 2.744

2.  Application of beta-blockers in burn management.

Authors:  Jonathan Kopel; Gregory L Brower; Grant Sorensen; John Griswold
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-22

3.  Reduced Postburn Hypertrophic Scarring and Improved Physical Recovery With Yearlong Administration of Oxandrolone and Propranolol.

Authors:  David Herndon; Karel D Capek; Evan Ross; Jayson W Jay; Anesh Prasai; Amina El Ayadi; Guillermo Foncerrada-Ortega; Elizabeth Blears; Christian Sommerhalder; Kara McMullen; Dagmar Amtmann; Robert Cox; Gabriel Hundeshagen; Kristofer Jennings; Linda E Sousse; Oscar E Suman; Walter J Meyer; Celeste C Finnerty
Journal:  Ann Surg       Date:  2018-09       Impact factor: 12.969

4.  Beta-blocker treatment in the critically ill: a systematic review and meta-analysis.

Authors:  Maria Heliste; Ville Pettilä; David Berger; Stephan M Jakob; Erika Wilkman
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.